APLS

APELLIS PHARMACEUTICALS INC

Healthcare | Mid Cap

-$0.39

EPS Forecast

$204.9

Revenue Forecast

Announcing earnings for the quarter ending 2026-03-31 soon

Proximilar's AI forecasts

EPS Forecast:

-$0.39

Revenue Forecast:

$204.9

EPS Surprise Forecast:

-$0.004

Revenue Surprise Forecast:

$4

Post-release price volatility - Very high

Post-release Overnight Move:

±10.2%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

51%

Probability of beating revenue consensus:

73%

Probability of beating both EPS & revs consensus:

43%

Probability of missing both EPS & revs consensus:

19%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

-2

Beta (β)

Forward Looking Beta (β):

0.92

Earnings volatility

EPS standard deviation:

$0.24

Revenue standard deviation:

$16

As % of share price:

1.35% VERY HIGH

As % of market cap:

0.71% MEDIUM

Confidence intervals and percentiles

EPS 95th %ile:

-$0.07

Revenue 95th %ile:

$226

EPS 75th %ile:

-$0.30

Revenue 75th %ile:

$210

EPS 25th %ile:

-$0.46

Revenue 25th %ile:

$200

EPS 5th %ile:

-$0.66

Revenue 5th %ile:

$187

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

42% HIGH

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

79% VERY HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$14

Bid-ask per Share:

$0.025